News
Historically, seizure action plans have focused on certain high-risk groups—such as people with drug-resistant epilepsy and ...
Medical Device Network on MSN1d
Epiminder’s implantable EEG system for epilepsy receives FDA authorisationAustralia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous electroencephalogram (EEG) monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback